PMVP FY 2019 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$84M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$388,000

Operating Income

-$27M

Net Income

-$25M

EPS (Diluted)

$-0.59

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$908,000

Balance Sheet

Total Assets

$103M

Total Liabilities

$174M

Stockholders' Equity

-$70M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$388,000	-$338,000	-14.8%
Operating Income	-$27M	-$19M	-41.0%
Net Income	-$25M	-$18M	-44.6%